RNA Based Therapeutics Market is expected to grow at a CAGR of 18.1% during the forecasted period | Evolve Business Intelligence

Key Highlights:
• The global RNA Based Therapeutics Market size was valued at USD 7.2 billion in 2023 growing at a CAGR of 18.1% from 2023 to 2033.
• North America dominated the market in 2023
• Asia Pacific is expected to grow at the highest CAGR from 2023 to 2033

As per the study initiated by Evolve Business Intelligence, the global RNA Based Therapeutics Market size accounted for USD 7.2 Billion in 2023, growing at a CAGR of 18.1% from 2023 to 2033. RNA-based therapeutics refer to a class of drugs that utilize ribonucleic acid (RNA) molecules to treat or prevent diseases. There are several types of RNA-based therapeutics, including messenger RNA (mRNA), small interfering RNA (siRNA), and antisense oligonucleotides (ASOs). These molecules can be designed to target specific genes or proteins, modulating their expression to achieve therapeutic effects.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021313

Continuous advancements in RNA technologies, such as improved delivery methods and enhanced stability of RNA molecules, have expanded the potential applications of RNA-based therapeutics. The rapid development and success of mRNA-based COVID-19 vaccines (Pfizer-BioNTech, Moderna) have increased confidence in the technology and stimulated interest and investment in RNA therapeutics. RNA-based therapeutics offer a targeted approach to treating genetic diseases by addressing the underlying genetic causes, making them attractive for conditions with limited treatment options. RNA-based therapies are being explored for rare diseases and orphan indications, where traditional drug development may be economically challenging.

Key Players
Some of the major RNA Therapeutics Market players holding high market shares include Gradalis, Inc., Genzyme (Sanofi), Alnylam Pharmaceuticals, Inc., Benitec Biopharma Inc., and Arbutus Biopharma Corporation. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Biogen, Inc., Ionis Pharmaceuticals, Sarepta Therapeutics, Silence Therapeutics plc, Arrowhead Pharmaceuticals

For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021313

Segmental Analysis
Based on type, the RNA Therapeutics market is segmented into RNA Interference (RNAi), and RNA Antisense. The RNAi segment is the largest in the RNA Therapeutics market. This is due to the potential of RNAi to target a wide range of diseases, including cancer, viral infections, and genetic disorders.
Based on application, the RNA Therapeutics market is a Genetic Disorder and autoimmune disorder. The genetic disorders segment is the largest in the RNA Therapeutics market. This is due to the increasing number of genetic disorders being diagnosed and the potential of RNA Therapeutics to provide a safe and effective treatment for these conditions.
Based on End Use, the RNA Therapeutics market is Research Institutes, Hospitals & Clinics. The hospitals & clinics segment is the largest in the RNA Therapeutics market. This is due to the increasing demand for RNA Therapeutics from patients and the growing number of clinical trials being conducted in hospitals and clinics.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.